Nov 21, 2017· Comment from American Pharmacists Association· FDA-2017-N-2936-0045
Please see attached for comments from the American Pharmacists Association.
FDANonrulemakingFDA-2017-N-2936
Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Request for Information and Comments
RIN
—
Last modified
Dec 18, 2017
Comment window
closed 3172d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Nov 21, 2017 and Nov 21, 2017. 6 other organizations filed here. The comment window closed 3172d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (6)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- Coalition for Healthcare Communicationtrade assoc.1 filing · confidence 85%
- Eli Lilly and Companyunverified attribution1 filing · confidence 70%
- Gilead Sciences Inc.unverified attribution1 filing · confidence 70%
- National Association of Broadcasterstrade assoc.1 filing · confidence 85%
- Pharmaceutical Care Management Associationtrade assoc.1 filing · confidence 85%
- The Association of Magazine Mediatrade assoc.1 filing · confidence 85%